Multiple Sclerosis
📧 Sign up to get email alerts when something new happens for Multiple Sclerosis.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS research · 2024-09-19Clinical Trial Update: Effect of Combined Exercise Training in Patients With Multiple Sclerosis [NA]
Clinical trial update on combined exercise training for patients with Multiple Sclerosis; the study is currently not yet recruiting.
-
FDA approval · 2024-09-13FDA Approved: OCREVUS ZUNOVO — Original Application (Genentech, Inc.)
FDA approved the original biologics license application for OCREVUS ZUNOVO (ocrelizumab and hyaluronidase) from Genentech. The product provi…
-
FDA approval · 2024-09-11FDA Approved: VUMERITY — Supplemental Application (Biogen Inc.)
FDA approved Biogen's supplemental application for VUMERITY (diroximel fumarate), updating/expanding its labeling for the treatment of multi…
-
CLINICAL_TRIALS research · 2024-09-03Clinical Trial Update: Enhancing Pelvic Floor Function With Transcranial Magnetic and Tibial Nerve Stimulation for Neurogenic Bladder in MS [NA]
A clinical trial registered as NCT06581341 is investigating transcranial magnetic stimulation and tibial nerve stimulation to improve pelvic…
-
FDA label_change · 2024-08-30FDA Approved: ZEPOSIA 7-DAY STARTER PACK — Supplemental Application (Celgene Corporation)
FDA approved a supplemental labeling to include a Zeposia 7-day starter pack for ozanimod hydrochloride.
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS research · 2024-08-29Clinical Trial Update: Virtual Reality in the Treatment of Pelvic Floor Dysfunction in Women With Multiple Sclerosis [NA]
A clinical trial evaluating virtual reality for treating pelvic floor dysfunction in women with multiple sclerosis is not yet recruiting.
-
CLINICAL_TRIALS trial_result · 2024-08-29Clinical Trial Update: Upper Extremity Motor Imagery Functional Skills and Quality of Life in Patients With Multiple Sclerosis
The study evaluating upper-extremity motor imagery to improve functional skill and quality of life in people with multiple sclerosis has com…
-
FDA approval · 2024-08-28FDA Approved: FINGOLIMOD — Supplemental Application (XLCare Pharmaceuticals Inc.)
The FDA approved a supplemental application for fingolimod filed by XLCare Pharmaceuticals Inc., indicating regulatory approval of a change …
-
FDA approval · 2024-08-22FDA Approved: TERIFLUNOMIDE — Supplemental Application (Mylan Pharmaceuticals Inc.)
FDA approved a supplemental application for teriflunomide from Mylan Pharmaceuticals Inc., authorizing a generic product. Teriflunomide is u…
-
CLINICAL_TRIALS trial_result · 2024-08-22Clinical Trial Update: The MS-LINK™ Outcomes Study
The MS-LINK Outcomes Study sponsored by EMD Serono has completed, with the trial status now marked as completed.
-
CLINICAL_TRIALS research · 2024-08-22Clinical Trial Update: Multiple Sclerosis Treatment With Autologous Hematopoietic Stem Cell Transplantation in the Netherlands
A Netherlands-based clinical study is currently recruiting relapsing-remitting multiple sclerosis patients to evaluate autologous hematopoie…
-
CLINICAL_TRIALS research · 2024-08-22Clinical Trial Update: Positive Psychological Interventions for Patients With Multiple Sclerosis [NA]
A clinical trial evaluating positive psychological interventions for patients with Multiple Sclerosis is currently enrolling by invitation.
-
CLINICAL_TRIALS trial_result · 2024-08-21Clinical Trial Update: Neural Mobilization on Multiple Sclerosis [NA]
A completed clinical trial from Kahramanmaras Sutcu Imam University evaluating neural mobilization as a treatment for multiple sclerosis.
-
CLINICAL_TRIALS research · 2024-08-16Clinical Trial Update: User-friendliness of a Portable Driving Simulator [NA]
This ClinicalTrials.gov study assesses the user-friendliness of a portable driving simulator for individuals with Parkinson disease, multipl…
-
CLINICAL_TRIALS research · 2024-08-14Clinical Trial Update: Non-invasive Electrical Spinal Cord Stimulation To Restore Upper Extremity Function in Multiple Sclerosis [Phase 1]
Phase 1 study assessing the feasibility and safety of non-invasive electrical spinal cord stimulation to improve upper-extremity function in…
-
CLINICAL_TRIALS trial_result · 2024-08-13Clinical Trial Update: Tolebrutinib, a Brain-penetrant Bruton's Tyrosine Kinase Inhibitor, for the Modulation of Chronically Inflamed White Matter Lesions in Multiple Sclerosis [Phase 2]
Phase 2 clinical trial update on tolebrutinib, a brain-penetrant Bruton's tyrosine kinase inhibitor, for modulation of chronically inflamed …
-
CLINICAL_TRIALS research · 2024-08-09Clinical Trial Update: Intermittent Fasting and Mediterranean Diet in Patient With Multiple Sclerosis [NA]
A clinical trial update indicates recruitment is ongoing for a study assessing intermittent fasting and a Mediterranean diet in patients wit…
-
CLINICAL_TRIALS withdrawal · 2024-08-09Clinical Trial Update: Assessing the Cognitive Benefits of Ozanimod and Their Brain-Biomarkers in MS [Phase 4]
The Phase 4 clinical trial evaluating cognitive benefits of ozanimod in multiple sclerosis, including brain biomarker analyses, has been wit…
-
FDA approval · 2024-08-07FDA Approved: TIZANIDINE — Original Application (Rising Pharma Holdings, Inc.)
FDA approved the original application for a generic version of tizanidine from Rising Pharma Holdings, Inc., enabling marketing of the drug …
-
CLINICAL_TRIALS research · 2024-08-07Clinical Trial Update: Sun Yat-Sen Cohort of CNS Idiopathic Inflammatory Demyelinating Diseases
Sun Yat-Sen Memorial Hospital is conducting a cohort study of CNS idiopathic inflammatory demyelinating diseases and is currently recruiting…
-
CLINICAL_TRIALS trial_result · 2024-08-06Clinical Trial Update: Evaluating Multiple Sclerosis Patients ShOWing A GEnomic Signature of Therapy Response
A completed clinical trial update from DxTerity Diagnostics evaluating a genomic signature associated with therapy response in patients with…
-
CLINICAL_TRIALS research · 2024-08-06Clinical Trial Update: Grey Matter Damage at the Earliest Phase of Multiple Sclerosis : a Longitudinal 7T MRI Study [NA]
This clinical trial update describes a longitudinal 7T MRI study investigating grey matter damage at the earliest stages of multiple scleros…
-
CLINICAL_TRIALS research · 2024-08-06Clinical Trial Update: MRI Study of the Mechanisms Underlying Irreversible Disability in Multiple Sclerosis [NA]
This clinical trial update reports an MRI study investigating the mechanisms underlying irreversible disability in multiple sclerosis; the s…
-
CLINICAL_TRIALS research · 2024-08-06Clinical Trial Update: Application of ihMT MRI in Multiple Sclerosis [NA]
This clinical trial update indicates ongoing recruitment for studying ihMT MRI imaging in patients with multiple sclerosis.
-
CLINICAL_TRIALS research · 2024-08-01Clinical Trial Update: Kesimpta Pregnancy and Infant Safety Study Using Real World Data
A Novartis-sponsored real-world data study is evaluating Kesimpta (ofatumumab) pregnancy and infant safety in people with multiple sclerosis…